Partain, Brittany D.
Bracho-Sanchez, Evelyn
Farhadi, Shaheen A.
Yarmola, Elena G.
Keselowsky, Benjamin G.
Hudalla, Gregory A.
Allen, Kyle D.
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR068424, R01AR071431, R01AR068424, R01AR071431, R01AR068424, R01AR071431, R01AR068424, R01AR071431, R01AR068424, R01AR071431, R01AR068424, R01AR071431, R01AR068424, R01AR071431)
National Institute of Dental and Craniofacial Research (R01DE027301, R01DE027301, R01DE027301, R01DE027301, R01DE027301, R01DE027301, R01DE027301)
Article History
Received: 29 March 2023
Accepted: 27 August 2023
First Online: 18 September 2023
Declarations
:
: All animal experiments were approved by the University of Florida Institutional Animal Care and Use Committee.
: Not applicable.
: KDA is part of a patent on the magnetic capture technology (US Patent No. 10,695,036). BGK and GAH are founders, hold stock, and serve on the scientific advisory board of Anchor Biologics, Inc. The University of Florida has pending patents related to molecules and their uses reported in this paper.